Positron Corp
OTC:POSC
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Positron Corp
OTC:POSC
|
34.8m USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
202.2B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.4B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
148B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
124.9B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
113.5B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.8B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.7B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.3B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50.3B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Positron Corp
Glance View
Positron Corp. operates as a nuclear medicine healthcare company specializing in the field of cardiac positron emission tomography imaging. The company is headquartered in Niagara Falls, New York. The firm is specialized in the field of cardiac PET imaging. Its PET technology, services and practice solutions enables healthcare providers to diagnose coronary artery disease and improve patient outcomes while practicing medicine. The firm offers nuclear cardiologists its Attrius PET scanner, service, clinical expertise and financing packages. Its PET imaging allows identification of coronary flow reserve, a measurement that detects the blood flow differences between rest and stress through the coronary arteries. Its Attrius PET scanner provides high system uptime, minimal radiation exposure and offers a conclusive diagnosis. The firm develops Attrius PET scanner to offer the cardiac PET imaging community a choice when comparing the purchase, install and on-going maintenance of a new PET/ computed tomography (CT) system.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 3 years, Positron Corp’s Gross Margin has increased from 27.3% to 33%. During this period, it reached a low of 7.1% on Dec 31, 2014 and a high of 33% on Oct 30, 2015.
